Fulcrum Therapeutics (FULC) FCF Margin (QoQ) (2020 - 2023)

Fulcrum Therapeutics (FULC) FCF Margin (QoQ) (2020 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Fulcrum Therapeutics 285.31 Mn 285.31 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 29,462.00
Sep 30, 2023 -66,389.00
Jun 30, 2023 588,504.00
Mar 31, 2023 -535,668.00
Dec 31, 2022 -53,039.00
Sep 30, 2022 -89,677.00
Jun 30, 2022 -58,670.00
Mar 31, 2022 -41,994.00
Dec 31, 2021 3,800.00
Sep 30, 2021 -7,826.00
Jun 30, 2021 -5,786.00
Mar 31, 2021 13,614.00
Dec 31, 2020 -19,255.00
Sep 30, 2020 41,272.00
Jun 30, 2020 134,833.00